Abbott launches SimpleScreen CRC blood test for average-risk adults 45+

▪ SCREENING

The FDA-approved blood-based screening test, developed by Freenome and sold exclusively by Abbott, is designed for adults unwilling or unable to undergo colonoscopy. (Fierce Biotech)